Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau

Age is the largest risk factor for Alzheimer’s disease (AD) and contributes to cognitive impairment in otherwise healthy individuals. Thus, it is critical that we better understand the risk aging presents to vulnerable regions of the brain and carefully design therapeutics to address those effects....

Full description

Bibliographic Details
Main Authors: Shannon N. Leslie, Dibyadeep Datta, Kyle R. Christensen, Christopher H. van Dyck, Amy F. T. Arnsten, Angus C. Nairn
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.576723/full
_version_ 1828840514468708352
author Shannon N. Leslie
Shannon N. Leslie
Dibyadeep Datta
Kyle R. Christensen
Christopher H. van Dyck
Christopher H. van Dyck
Christopher H. van Dyck
Amy F. T. Arnsten
Angus C. Nairn
author_facet Shannon N. Leslie
Shannon N. Leslie
Dibyadeep Datta
Kyle R. Christensen
Christopher H. van Dyck
Christopher H. van Dyck
Christopher H. van Dyck
Amy F. T. Arnsten
Angus C. Nairn
author_sort Shannon N. Leslie
collection DOAJ
description Age is the largest risk factor for Alzheimer’s disease (AD) and contributes to cognitive impairment in otherwise healthy individuals. Thus, it is critical that we better understand the risk aging presents to vulnerable regions of the brain and carefully design therapeutics to address those effects. In this study we examined age-related changes in cAMP-regulatory protein, phosphodiesterase 4D (PDE4D). Inhibition of PDE4D is currently under investigation as a therapeutic target for AD based on memory-enhancing effects in rodent hippocampus. Therefore, it is important to understand the role of PDE4D in brain regions particularly vulnerable to disease such as the frontal association cortex (FC), where cAMP signaling can impair working memory via opening of potassium channels. We found that PDE4D protein level was decreased in the FC of both moderately and extremely aged rats, and that PDE4D level was correlated with performance on a FC-dependent working memory task. In extremely aged rats, PDE4D was also inversely correlated with levels of phosphorylated tau at serine 214 (S214), a site phosphorylated by protein kinase A. In vitro studies of the PDE4D inhibitor, GEBR-7b, further illustrated that inhibition of PDE4D activity enhanced phosphorylation of tau. pS214-tau phosphorylation is associated with early AD tau pathology, promotes tau dissociation from microtubules and primes subsequent tau hyperphosphorylation at other critical AD-related sites. Age-related loss of PDE4D may thus contribute to the specific vulnerability of the FC to degeneration in AD, and play a critical role in normal cAMP regulation, cautioning against the use of pan-PDE4D inhibitors as therapeutics.
first_indexed 2024-12-12T19:42:40Z
format Article
id doaj.art-79e9bc0a54fd40069af7bd4e5a5abb26
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-12T19:42:40Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-79e9bc0a54fd40069af7bd4e5a5abb262022-12-22T00:14:09ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-10-011210.3389/fnagi.2020.576723576723Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of TauShannon N. Leslie0Shannon N. Leslie1Dibyadeep Datta2Kyle R. Christensen3Christopher H. van Dyck4Christopher H. van Dyck5Christopher H. van Dyck6Amy F. T. Arnsten7Angus C. Nairn8Interdepartmental Neuroscience Program, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Psychiatry, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Neuroscience, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Psychiatry, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Psychiatry, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Neuroscience, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Neurology, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Neuroscience, Yale University, School of Medicine, New Haven, CT, United StatesDepartment of Psychiatry, Yale University, School of Medicine, New Haven, CT, United StatesAge is the largest risk factor for Alzheimer’s disease (AD) and contributes to cognitive impairment in otherwise healthy individuals. Thus, it is critical that we better understand the risk aging presents to vulnerable regions of the brain and carefully design therapeutics to address those effects. In this study we examined age-related changes in cAMP-regulatory protein, phosphodiesterase 4D (PDE4D). Inhibition of PDE4D is currently under investigation as a therapeutic target for AD based on memory-enhancing effects in rodent hippocampus. Therefore, it is important to understand the role of PDE4D in brain regions particularly vulnerable to disease such as the frontal association cortex (FC), where cAMP signaling can impair working memory via opening of potassium channels. We found that PDE4D protein level was decreased in the FC of both moderately and extremely aged rats, and that PDE4D level was correlated with performance on a FC-dependent working memory task. In extremely aged rats, PDE4D was also inversely correlated with levels of phosphorylated tau at serine 214 (S214), a site phosphorylated by protein kinase A. In vitro studies of the PDE4D inhibitor, GEBR-7b, further illustrated that inhibition of PDE4D activity enhanced phosphorylation of tau. pS214-tau phosphorylation is associated with early AD tau pathology, promotes tau dissociation from microtubules and primes subsequent tau hyperphosphorylation at other critical AD-related sites. Age-related loss of PDE4D may thus contribute to the specific vulnerability of the FC to degeneration in AD, and play a critical role in normal cAMP regulation, cautioning against the use of pan-PDE4D inhibitors as therapeutics.https://www.frontiersin.org/articles/10.3389/fnagi.2020.576723/fulltauworking memoryPDE4DagingAlzheimer’s disease
spellingShingle Shannon N. Leslie
Shannon N. Leslie
Dibyadeep Datta
Kyle R. Christensen
Christopher H. van Dyck
Christopher H. van Dyck
Christopher H. van Dyck
Amy F. T. Arnsten
Angus C. Nairn
Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
Frontiers in Aging Neuroscience
tau
working memory
PDE4D
aging
Alzheimer’s disease
title Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
title_full Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
title_fullStr Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
title_full_unstemmed Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
title_short Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau
title_sort phosphodiesterase pde4d is decreased in frontal cortex of aged rats and positively correlated with working memory performance and inversely correlated with pka phosphorylation of tau
topic tau
working memory
PDE4D
aging
Alzheimer’s disease
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.576723/full
work_keys_str_mv AT shannonnleslie phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT shannonnleslie phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT dibyadeepdatta phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT kylerchristensen phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT christopherhvandyck phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT christopherhvandyck phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT christopherhvandyck phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT amyftarnsten phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau
AT anguscnairn phosphodiesterasepde4disdecreasedinfrontalcortexofagedratsandpositivelycorrelatedwithworkingmemoryperformanceandinverselycorrelatedwithpkaphosphorylationoftau